Coates, Philip J.
Nenutil, Rudolf
Holcakova, Jitka
Nekulova, Marta
Podhorec, Jan
Svoboda, Marek
Vojtesek, Borivoj
Article History
Received: 8 September 2017
Revised: 2 February 2018
Accepted: 15 February 2018
First Online: 27 February 2018
Compliance with ethical standards
: All patient data were anonymised, and the study was performed retrospectively on redundant excess tissues following ethical approval by the Biobanking and Biomolecular resources Research Infrastructure (BBMRI) at MMCI, in accordance with European Union regulations and the Declaration of Helsinki.
: BV is a consultant for and RN is a co-owner of Moravian Biotechnology, who produces the p63 isoform-specific antibodies used in this study. The company did not provide financial support or have any influence over the design or execution of the studies. All other authors declare that they have no conflicts of interest.